PATENT CLAIM ANALYSIS

Application Number: 15933619
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-10
Patent Classification: ["424", "140100"]

Abstract:
Disclosed is a method for treating of Cockayne Syndrome (CS). Specifically, the invention pertains to a method for the extracorporeal treatment of a body fluid by removing the body fluid from a living body diseased with CS, and applying a targeted antibody conjugated to a moiety to at least one Cockayne Syndrome antigen in the body fluid, creating an antibody-antigen moiety complex, removing antibody-antigen moiety complex from the body fluid, and returning the purified body fluid to the body.

Claim (Index 9):
The method of  claim 1  wherein removing the CSTA targeted antibody-CSTA complexes from the body fluid is done using zeolite.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 90.0
- Lexical Diversity: 1.91304
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15647850', '14978910', '09562245', '13254855', '10461885']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6732952213222199
- 35 USC 102 Novelty (BERT): 0.462757399597734
- Combined Prediction Score: 0.6522414391497713
- Mean Citation Score: 130.47465
- Max Citation Score: 132.54641999999998
- Similarity Product: 104.92223563267348

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test